Dr. Yuyan Jin received her Ph.D. in Clinical Pharmacology from the University of Pittsburgh, served as a critical path fellow for two years at FDA, and completed a one-year global clinical scholar program at Harvard Medical School. Prior to joining SanegeneBio, Dr. Jin worked at Pfizer U.S. and Roche China Innovation Center for 15+ years, where she has led and engaged in preclinical research, early clinical development, and regulatory submissions for multiple innovative programs across neuroscience, oncology, infection, and immunology diseases. Dr. Jin has also contributed to multiple technical guidance in China as a member of the scientific expert committee. She has numerous scientific publications and serves as a reviewer for several internationally recognized journals, such as <Clinical Pharmacology and Therapeutics>, <Journal of Clinical Pharmacology>, <British Journal of Clinical Pharmacology>.